Kelonia Therapeutics Patents – Insights & Stats (Updated 2024)

Kelonia Therapeutics has a total of 9 patents globally, out of which no patents have been granted. Of these 9 patents, more than 88% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kelonia Therapeutics.

Kelonia Therapeutics was founded in the year 2017. The Company is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.

Do read about some of the most popular patents of Kelonia Therapeutics which have been covered by us in this article and also you can find Kelonia Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kelonia Therapeutics patent portfolio.

How many patents does Kelonia Therapeutics have?

Kelonia Therapeutics has a total of 9 patents globally. These patents belong to 1 unique patent families. Out of 9 patents, 8 patents are active.

How Many Patents did Kelonia Therapeutics File Every Year?

Kelonia Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantKelonia Therapeutics Applications FiledKelonia Therapeutics Patents Granted
20232
20227

How many Kelonia Therapeutics patents are Alive/Dead?

Kelonia Therapeutics Patent Portfolio

How Many Patents did Kelonia Therapeutics File in Different Countries?

Kelonia Therapeutics Worldwide Patent Filing

Countries in which Kelonia Therapeutics Filed Patents

CountryPatents
Australia1
Brazil1
Canada1
Europe1
India1
Israel1
Mexico1
New Zealand1

Where are Research Centres of Kelonia Therapeutics Patents Located?

The Research Centre for all the Kelonia Therapeutics patents is the United States of America.

List of Kelonia Therapeutics Patents

Kelonia Therapeutics PatentsTitle
EP4298114A1Lymphocyte Targeted Lentiviral Vectors
IN202317060765ALymphocyte Targeted Lentiviral Vectors
MX2023009910ALentiviral Vectors Directed To Lymphocytes
BR112023017213A2Lentiviral Vectors Targeting Lymphocytes
IL305411ALymphocyte Targeted Lentiviral Vectors
AU2022227021A1Lymphocyte Targeted Lentiviral Vectors
NZ803269ALymphocyte Targeted Lentiviral Vectors
CA3212006A1Lymphocyte Targeted Lentiviral Vectors
WO2022183072A1Lymphocyte Targeted Lentiviral Vectors

What are Kelonia Therapeutics key innovation segments?

What Technologies are Covered by Kelonia Therapeutics?

The chart below distributes patents filed by Kelonia Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Kelonia Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Kelonia Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Kelonia Therapeutics?

Related Articles

Weo Llc Patents – Insights & Stats (Updated 2024)

Weo Llc has a total of 47 patents globally, out of which 9 have been granted. Of these 47 patents, more than 87% patents are active. The United States of America is where Weo Llc has filed the maximum number of patents, followed by Brazil and Australia. Parallelly, France seems

Read More »

Fortephest Patents – Insights & Stats (Updated 2024)

Fortephest has a total of 23 patents globally. Of these 23 patents, more than 91% patents are active. Argentina is where Fortephest has filed the maximum number of patents, followed by New Zealand and Australia. Parallelly, The United States of America seems to be the main focused R&D center and

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.